Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureShu Liu, Hiu Ying Enne Leung, Arun D. Singh, Martine J. Jager, Xianqun Fan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study
10.1200/jco-26-00835 · 2026
Unresolved referenced work
2026
Unresolved referenced work
2025
Cutaneous Melanoma in Asians
10.4068/cmj.2016.52.3.185 · 2016
10.1038/s41572-020-0158-0
10.1038/s41572-020-0158-0 · 2020
Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors
10.1167/iovs.64.13.45 · 2023
Correlation of Fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma
2024
Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology center
2024
Genomic and transcriptomic landscape of conjunctival melanoma
10.1371/journal.pgen.1009201 · 2020
Confidence 0%
Uveal melanoma: Current evidence on prognosis, treatment and potential developments
2024
An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification – A prospective study
2024
Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma
2024
Targeted therapy in ophthalmic oncology: The current status
2024
Uveal Melanoma: Identifying Immunological and Chemotherapeutic Targets to Treat Metastases
2017
Conjunctival melanoma in aotearoa-New Zealand: a 21-year analysis of incidence and survival
10.1097/apo.0000000000000606 · 2023
No additional external references are available.